LY3023414, a dual PI3K/MTOR inhibitor, decreases cell proliferation in colorectal cancer cells as well as a reducing the growth of PIK3CA-mutant colon tumors in vivo [19]. Here, PIK3CA is linked to colonic neoplasm.